(Q36649568)

English

Glycated hemoglobin as a marker of cardiovascular risk

scientific article published on December 2006

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

title

Glycated hemoglobin as a marker of cardiovascular risk (English)

1 reference

stated in

Europe PubMed Central

15 August 2017

1 reference

glycated hemoglobin

23 October 2023

1

Kay-Tee Khaw

1 reference

stated in

Europe PubMed Central

15 August 2017

2

Nicholas Wareham

1 reference

stated in

Europe PubMed Central

15 August 2017

1 December 2006

1 reference

stated in

Europe PubMed Central

15 August 2017

Current Opinion in Lipidology

1 reference

stated in

Europe PubMed Central

15 August 2017

17

1 reference

stated in

Europe PubMed Central

15 August 2017

637-643

1 reference

stated in

Europe PubMed Central

15 August 2017

6

1 reference

stated in

Europe PubMed Central

15 August 2017

Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Standardization of HbA1c measurements--a consensus statement

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Strategy of prevention: lessons from cardiovascular disease.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Global and societal implications of the diabetes epidemic

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Glycosylated Hemoglobin: Finally Ready for Prime Time as a Cardiovascular Risk Factor

2 references

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.7326/0003-4819-141-6-200409210-00014

Lilly Lecture 1993. Glycation and diabetic complications

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

0 references

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

2 references

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.7326/0003-4819-141-6-200409210-00007

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

The influence of type 2 diabetes on fibrin structure and function

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

The prevention or delay of type 2 diabetes

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

New diagnostic criteria and classification of diabetes--again?

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Glucose: a continuous risk factor for cardiovascular disease.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Relationship between HbA1c level and peripheral arterial disease

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

The association of glycemia and cause-specific mortality in a diabetic population

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus

2 references

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1056/NEJM199505113321902

Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Standards of medical care for patients with diabetes mellitus

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Physical activity/exercise and diabetes mellitus

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Hemoglobin A1c level and future cardiovascular events among women

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Is diet the cornerstone in management of diabetes?

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Glycosylated hemoglobin level and carotid intimal-medial thickening in nondiabetic individuals. The Atherosclerosis Risk in Communities Study.

2 references

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.2337/DIACARE.20.9.1454

Tests of glycemia in diabetes

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

The pathobiology of diabetic complications: a unifying mechanism

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1097/MOL.0B013E3280106B95

Identifiers

DOI

10.1097/MOL.0B013E3280106B95

1 reference

stated in

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

PubMed ID

17095908

retrieved

15 August 2017

(Q36649568)

Glycated hemoglobin as a marker of cardiovascular risk

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)